Open AccessAssessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease
Author(s) -
Nielsen Søren Saxmose,
Alvarez Julio,
Bicout Dominique Joseph,
Calistri Paolo,
Canali Elisabetta,
Drewe Julian Ashley,
GarinBastuji Bruno,
Gonzales Rojas José Luis,
Gortázar Schmidt Christian,
Herskin Mette,
Michel Virginie,
Miranda Chueca Miguel Ángel,
Padalino Barbara,
Pasquali Paolo,
Sihvonen Liisa Helena,
Spoolder Hans,
Ståhl Karl,
Velarde Antonio,
Viltrop Arvo,
Winckler Christoph,
De Clercq Kris,
Gubbins Simon,
Klement Eyal,
Stegeman Jan Arend,
Antoniou SotiriaEleni,
Aznar Inma,
Broglia Alessandro,
Van der Stede Yves,
Zancanaro Gabriele,
Roberts Helen Clare
Publication year - 2022
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2022.7121
Subject(s) - european commission , legislation , transmission (telecommunications) , mandate , health claims on food labels , environmental health , medicine , veterinary medicine , european union , law , political science , business , computer science , biology , telecommunications , food science , economic policy
EFSA received a mandate from the EC to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation ( EU ) 2016/429 on transmissible animal diseases (‘Animal Health Law’). This opinion belongs to a series of opinions where these control measures are assessed, with this opinion covering the assessment of control measures for Lumpy Skin Disease ( LSD ). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) the minimum radius of the protection and surveillance zones, and the minimum length of time that measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. The monitoring period was assessed as effective, and based on the transmission kernels available, it was concluded that the protection zone of 20 km radius and the surveillance zone of 50 km radius would comprise > 99% of the transmission from an affected establishment if transmission occurred. Recommendations provided for each of the assessed scenarios aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to LSD .